Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | CRHBP | P24387 | 2/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900908 | 0.80 | MAPT (0.33) | CYP1A2CYP2C9SMN1; SMN2MEN1KMT2A | |
| SCHEMBL11224081 | 0.80 | LMNA (0.33) | LMNAHTT | |
| SCHEMBL1828313 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL2290692 | 0.78 | CYP1A2 (0.50) | CYP1A2CYP2C9LMNASMN1; SMN2CRHBP | |
| SCHEMBL76560 | 0.78 | LMNA (0.32) | LMNAHTTKMT2AALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL7459719 | 0.76 | PABPC1 (0.32) | LMNAHTTKMT2AALDH1A1HPGD | |
| SCHEMBL5392162 | 0.74 | ORAI1 (0.38) | LMNAMEN1KMT2ATSHRORAI1 | |
| SCHEMBL1977562 | 0.74 | LMNA (0.31) | LMNA | |
| SCHEMBL15293601 | 0.74 | CYP1A2 (0.43) | CYP1A2CYP2C9LMNASMN1; SMN2CRHBP | |
| SCHEMBL22468064 | 0.74 | SLC6A2 (0.32) | CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11469448-B2 | Electrolyte additive, electrolyte and lithium ion secondary battery containing the same | MURATA MANUFACTURING CO., LTD. (JP) | 2022-10-11 | — | — | US | disclosed |
| CN-111755749-A | Electrolyte additive, electrolyte and lithium ion secondary battery comprising same | 株式会社村田制作所 | 2020-10-09 | — | — | CN | disclosed |
| US-20200313239-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE AND LITHIUM ION SECONDARY BATTERY CONTAINING THE SAME | MURATA MANUFACTURING CO., LTD. (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20160002185-A1 | CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2016-01-07 | — | — | US | disclosed |
| EP-0748320-A1 | PRODRUGS OF MORPHOLINE TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO. INC. (US) | 1996-12-18 | — | — | EP | disclosed |
| US-4453967-A | Homobrassinolide compounds which are steroids having plant growth promoting activity | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-06-12 | — | — | US | disclosed |
| US-4335052-A | OXIDATION OF CORRESPONDING BENZYL HALIDE WITH TERITARY AMINE OXIDEIN PRESENCE OF WATER | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1982-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002185-A1 | CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | MDM2, TP53, MDM4 | CYP1A2 1976/4885CYP2C9 2187/4885LMNA 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.